{"schema_version":"secwatch.filing_event.v1","accession":"0001140361-25-007063","form_type":"8-K","ticker":"GALT","cik":"0001133416","company_name":"GALECTIN THERAPEUTICS INC","filed_at":"2025-03-05T23:59:59+00:00","discovered_at":"2026-05-14T18:03:03.010004+00:00","generated_at":"2026-05-25T09:28:31.887737+00:00","sec_items":["7.01","9.01"],"event_type":"other","sentiment":"neutral","materiality_score":0.15,"calibrated_materiality_score":0.15,"confidence":"low","headline":"Galectin Therapeutics updates corporate presentation; no specific data in filing excerpt","bullets":["Filing indicates updated corporate presentation posted on website March 5, 2025.","Presentation intended for use at conferences and investor meetings.","Exhibit content (slides) not included in provided text, limiting extractable news.","No new financial guidance, clinical milestones, or operational changes disclosed."],"urls":{"canonical":"https://secwatch.observer/filing/0001140361-25-007063","json":"https://secwatch.observer/filing/0001140361-25-007063.json","markdown":"https://secwatch.observer/filing/0001140361-25-007063.md","text":"https://secwatch.observer/filing/0001140361-25-007063.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1133416/000114036125007063/0001140361-25-007063-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1133416/000114036125007063/ef20044880_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-25T09:28:31.887737+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}